within Pharmacolibrary.Drugs.ATC.V;

model V03AB15
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.36666666666666664,
    adminDuration  = 600,
    adminMass      = 0.0004,
    adminCount     = 1,
    Vd             = 0.002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Naloxone is a non-selective and competitive opioid receptor antagonist used to rapidly reverse opioid overdose and opioid-induced respiratory depression. It is approved for use in emergency settings by various routes including intravenous, intramuscular, subcutaneous, and intranasal administration.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters derived from healthy adult volunteers following intravenous administration.</p><h4>References</h4><ol><li><p>Saari, TI, et al., &amp; Dale, O (2024). Clinical Pharmacokinetics and Pharmacodynamics of Naloxone. <i>Clinical pharmacokinetics</i> 63(4) 397–422. DOI:<a href=&quot;https://doi.org/10.1007/s40262-024-01355-6&quot;>10.1007/s40262-024-01355-6</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38485851/&quot;>https://pubmed.ncbi.nlm.nih.gov/38485851</a></p></li><li><p>Wahler, BM, et al., &amp; Aarnes, TK (2019). Pharmacokinetics and pharmacodynamics of intranasal and intravenous naloxone hydrochloride administration in healthy dogs. <i>American journal of veterinary research</i> 80(7) 696–701. DOI:<a href=&quot;https://doi.org/10.2460/ajvr.80.7.696&quot;>10.2460/ajvr.80.7.696</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31246123/&quot;>https://pubmed.ncbi.nlm.nih.gov/31246123</a></p></li><li><p>Dowling, J, et al., &amp; Graudins, A (2008). Population pharmacokinetics of intravenous, intramuscular, and intranasal naloxone in human volunteers. <i>Therapeutic drug monitoring</i> 30(4) 490–496. DOI:<a href=&quot;https://doi.org/10.1097/FTD.0b013e3181816214&quot;>10.1097/FTD.0b013e3181816214</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18641540/&quot;>https://pubmed.ncbi.nlm.nih.gov/18641540</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end V03AB15;
